Publication Month: Oct 2021 | Report Code: TIPRE00025127 | No. of Pages: 171 | Category: Biotechnology | Status: Published
Metabolomics is the study and analysis of biological processes involving metabolic intermediates and byproducts—metabolomes. The metabolomes include secondary metabolites, signaling molecules, hormones, and metabolic intermediates.
The report offers an in-depth analysis of the metabolomics services market, emphasizing on market trends, technological advancements, market dynamics, and competitive landscape (involving major market players across the world). It also includes the impact of the COVID-19 pandemic on the market across all the major regions. North America holds the largest market share, and the market growth in this region is attributed to high awareness and acceptance for metabolomics services, increasing number of online retails, and rising number of product innovations and launches. Moreover, the growing spending by sex technology companies are also likely to have positive impact on the North America metabolomics services market during the forecast period. The market, by region, is segmented into North America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA), and South and Central America (SAM).
Get more information on this report :
Metabolomics is among the growing and robust technologies for detecting a wide range of metabolites in tissues and biofluids. This process has a significant application in the analysis and studies associated with cancer disease. The rising prevalence of different types of cancer is expected to drive the market during the forecast period. Cancer diagnostics play an essential role in cancer treatment. As per the data published by the World Health Organization (WHO) in September 2021, nearly 70% of deaths from cancer were reported from the low- and middle-income countries across the globe. The total global share of cancer incidence share as per the Global Cancer Observatory records are breast (2.26 million cases 11.7%), lung (2.21 million cases 11.4%), colon and rectum (1.93 million cases 10%), prostate (1.41 million cases 7.3%), stomach (1.09 million cases 5.6%). Below are the details regarding the regional prevalence in 2020:
Get more information on this report :
The metabolomics services market, based on service type, has been segmented into targeted metabolomics service and untargeted metabolomics service. The targeted metabolomics service segment is likely to hold a larger market share in 2021. Moreover, the targeted metabolomics service segment is anticipated to register a higher CAGR in the market during the forecast period.
Get more information on this report :
The metabolomics services market, based on application, is segmented into pharmaceutical and biotechnology industry, agritech, and environment. The pharmaceutical and biotechnology industry segment is likely to hold the largest share of the market in 2021. Moreover, the market for this segment is expected to grow at the fastest CAGR of 21.6% during 2021 to 2028.
The metabolomics services market players adopt organic strategies such as product launch and expansion to expand their global footprint and product portfolio.
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.